• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同标本固定和处理方法的细胞块中程序性死亡配体1免疫组化表达的特征分析

Characterization of PD-L1 Immunohistochemical Expression in Cell Blocks With Different Specimen Fixation and Processing Methods.

作者信息

Lloyd Isaac E, Zhou Wenhua, Witt Benjamin L, Chadwick Barbara E

机构信息

Department of Pathology and ARUP Laboratories, University of Utah.

Research & Development, ARUP Laboratories, Salt Lake City, UT.

出版信息

Appl Immunohistochem Mol Morphol. 2019 Feb;27(2):107-113. doi: 10.1097/PAI.0000000000000572.

DOI:10.1097/PAI.0000000000000572
PMID:29084060
Abstract

Interpretative criteria for programmed death-ligand 1 (PD-L1) immunohistochemistry (IHC) have been largely based on data from formalin-fixed, paraffin-embedded tissues, despite the fact that cytologic specimens, especially cell blocks, are often the only or most readily available tissue for testing. Unlike biopsy specimens, however, cytology sample processing methods can vary markedly. The purpose of this study was to evaluate the effects of several common preanalytic variables on PD-L1 IHC. Two cell lines with strong expression of PD-L1 (H441) and no expression (MCF7) were cultured in vitro. Harvested cells were collected in PreservCyt, CytoLyt, cell culture media (RPMI), saline, and formalin. Cell blocks were prepared by the plasma-thromboplastin method or Cellient automated system and stained with the FDA-approved 28-8 PD-L1 antibody per protocol. PD-L1 expression was scored manually by 3 pathologists for stain intensity and localization and compared across preparation methods. Several IHC staining patterns were observed: complete membranous, partial membranous, globular, and cytoplasmic, with some overlap. Cellient blocks had the best interobserver agreement and cytomorphology, highest proportion of strong complete membranous staining (82%), and least amount of cytoplasmic (11%) and globular staining (8%). RPMI, saline, and formalin samples demonstrated increased amounts of cytoplasmic and globular staining relative to Cellient, while CytoLyt exhibited the poorest performance overall. Interpretation of PD-L1 IHC on cell blocks is feasible for most processing methods examined, but may require recognition of increased cytoplasmic and globular staining in some sample types. Cellient cell blocks demonstrated superior performance compared with other methods.

摘要

程序性死亡配体1(PD-L1)免疫组织化学(IHC)的解释标准很大程度上基于来自福尔马林固定、石蜡包埋组织的数据,尽管事实上细胞学标本,尤其是细胞块,往往是唯一可用于检测的组织或最容易获得的检测组织。然而,与活检标本不同,细胞学样本的处理方法可能有显著差异。本研究的目的是评估几种常见的分析前变量对PD-L1 IHC的影响。将两种PD-L1表达强(H441)和无表达(MCF7)的细胞系进行体外培养。收获的细胞收集于PreservCyt、CytoLyt、细胞培养基(RPMI)、生理盐水和福尔马林中。通过血浆凝血酶原方法或Cellient自动化系统制备细胞块,并按照方案用FDA批准的28-8 PD-L1抗体进行染色。3名病理学家对PD-L1表达进行手动评分,评估染色强度和定位,并比较不同制备方法的结果。观察到几种IHC染色模式:完全膜性、部分膜性、球状和细胞质性,存在一些重叠。Cellient细胞块在观察者间一致性和细胞形态方面表现最佳,强完全膜性染色比例最高(82%),细胞质性染色(11%)和球状染色(8%)最少。与Cellient相比,RPMI、生理盐水和福尔马林样本的细胞质性和球状染色量增加,而CytoLyt总体表现最差。对于大多数所检测的处理方法,对细胞块进行PD-L1 IHC解释是可行的,但可能需要认识到某些样本类型中细胞质性和球状染色增加的情况。与其他方法相比,Cellient细胞块表现出卓越的性能。

相似文献

1
Characterization of PD-L1 Immunohistochemical Expression in Cell Blocks With Different Specimen Fixation and Processing Methods.不同标本固定和处理方法的细胞块中程序性死亡配体1免疫组化表达的特征分析
Appl Immunohistochem Mol Morphol. 2019 Feb;27(2):107-113. doi: 10.1097/PAI.0000000000000572.
2
Formalin fixation for optimal concordance of programmed death-ligand 1 immunostaining between cytologic and histologic specimens from patients with non-small cell lung cancer.福尔马林固定可提高非小细胞肺癌患者细胞学和组织学标本中程序性死亡配体 1 免疫染色的一致性。
Cancer Cytopathol. 2021 Apr;129(4):304-317. doi: 10.1002/cncy.22383. Epub 2020 Oct 27.
3
Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma.一种经验证可用于分析非小细胞肺癌和头颈部鳞状细胞癌的程序性细胞死亡配体-1免疫组织化学检测方法的开发。
Diagn Pathol. 2016 Oct 8;11(1):95. doi: 10.1186/s13000-016-0545-8.
4
Programmed death ligand 1 testing in non-small cell lung carcinoma cytology cell block and aspirate smear preparations.程序性死亡配体 1 检测在非小细胞肺癌细胞学细胞块和抽吸涂片制备中的应用。
Cancer Cytopathol. 2018 May;126(5):342-352. doi: 10.1002/cncy.21987. Epub 2018 Mar 2.
5
Validation of 31 of the most commonly used immunohistochemical antibodies in cytology prepared using the Cellient(®) automated cell block system.使用Cellient®自动细胞块系统制备的细胞学样本中31种最常用免疫组化抗体的验证。
Diagn Cytopathol. 2014 Dec;42(12):1024-33. doi: 10.1002/dc.23155. Epub 2014 Mar 27.
6
Cytology cell blocks from malignant pleural effusion are good candidates for PD-L1 detection in advanced NSCLC compared with matched histology samples.与匹配的组织学样本相比,来自恶性胸腔积液的细胞学细胞块是晚期 NSCLC 中 PD-L1 检测的良好候选物。
BMC Cancer. 2020 Apr 22;20(1):344. doi: 10.1186/s12885-020-06851-z.
7
Cytologic-histologic correlation of programmed death-ligand 1 immunohistochemistry in lung carcinomas.肺癌中程序性死亡配体 1 免疫组化的细胞-组织学相关性。
Cancer Cytopathol. 2018 Apr;126(4):253-263. doi: 10.1002/cncy.21973. Epub 2018 Feb 5.
8
Programmed death-ligand 1 immunoexpression in matched biopsy and liquid-based cytology samples of advanced stage non-small cell lung carcinomas.晚期非小细胞肺癌配对活检和液基细胞学样本中程序性死亡配体1的免疫表达情况
Cytopathology. 2018 Dec;29(6):550-557. doi: 10.1111/cyt.12605. Epub 2018 Jul 30.
9
Association Between Formalin Fixation Time and Programmed Cell Death Ligand 1 Expression in Patients With Non-Small Cell Lung Cancer.非小细胞肺癌患者中福尔马林固定时间与程序性细胞死亡配体1表达之间的关联
Anticancer Res. 2019 May;39(5):2561-2567. doi: 10.21873/anticanres.13378.
10
Impact of delayed fixation and decalcification on PD-L1 expression: a comparison of two clones.固定和脱钙时间延迟对 PD-L1 表达的影响:两种克隆的比较。
Virchows Arch. 2019 Dec;475(6):693-699. doi: 10.1007/s00428-019-02613-w. Epub 2019 Jul 2.

引用本文的文献

1
Assessing PD-L1 expression in non-small cell lung carcinoma: a prospective study of matched fine-needle aspirates, core biopsies, and resection specimens using alcohol and forming fixatives.评估非小细胞肺癌中程序性死亡受体配体1(PD-L1)的表达:一项对匹配的细针穿刺抽吸物、芯针活检标本和手术切除标本使用酒精和成型固定剂的前瞻性研究。
J Pathol Clin Res. 2025 Sep;11(5):e70041. doi: 10.1002/2056-4538.70041.
2
Nationwide differences in cytology fixation and processing methods and their impact on interlaboratory variation in PD-L1 positivity.细胞学固定和处理方法的全国性差异及其对 PD-L1 阳性率的实验室间差异的影响。
Virchows Arch. 2023 Apr;482(4):707-720. doi: 10.1007/s00428-022-03446-w. Epub 2022 Nov 12.
3
Program death ligand-1 immunocytochemistry in lung cancer cytological samples: A systematic review.
程序性死亡配体-1 免疫细胞化学在肺癌细胞学样本中的应用:系统评价。
Diagn Cytopathol. 2022 Jun;50(6):313-323. doi: 10.1002/dc.24955. Epub 2022 Mar 16.
4
Study on PD-L1 Expression in NSCLC Patients and Related Influencing Factors in the Real World.非小细胞肺癌患者 PD-L1 表达的真实世界研究及相关影响因素分析。
Comput Math Methods Med. 2021 Dec 28;2021:3273347. doi: 10.1155/2021/3273347. eCollection 2021.
5
PD-L1 in Cytological Samples: A Review and a Practical Approach.细胞学样本中的程序性死亡受体配体1:综述与实用方法
Front Med (Lausanne). 2021 May 7;8:668612. doi: 10.3389/fmed.2021.668612. eCollection 2021.
6
PD-L1 and beyond: Immuno-oncology in cytopathology.PD-L1 及其他:细胞病理学中的免疫肿瘤学。
Cytopathology. 2021 Sep;32(5):596-603. doi: 10.1111/cyt.12982. Epub 2021 May 6.
7
False-negative programmed death-ligand 1 immunostaining in ethanol-fixed endobronchial ultrasound-guided transbronchial needle aspiration specimens of non-small-cell lung cancer patients.非小细胞肺癌患者经支气管超声引导针吸活检标本中乙醇固定导致程序性死亡配体 1 免疫染色假阴性。
Histopathology. 2021 Oct;79(4):480-490. doi: 10.1111/his.14373. Epub 2021 Jun 8.
8
The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC.国际肺癌研究协会非小细胞肺癌程序性死亡配体 1 检测全球调查。
J Thorac Oncol. 2021 Apr;16(4):686-696. doi: 10.1016/j.jtho.2020.12.026. Epub 2021 Mar 2.
9
Cell-blocks and immunohistochemistry.细胞块与免疫组织化学。
Cytojournal. 2021 Jan 30;18:2. doi: 10.25259/Cytojournal_83_2020. eCollection 2021.
10
Predictive biomarkers for response to immune checkpoint inhibitors in lung cancer: PD-L1 and beyond.预测免疫检查点抑制剂治疗肺癌反应的生物标志物:PD-L1 及其他。
Virchows Arch. 2021 Jan;478(1):31-44. doi: 10.1007/s00428-021-03030-8. Epub 2021 Jan 24.